Dr James Veltmeyer’s research Twitter discussing latest advances in stem cell research. Chief Medical Officer of TSOI and Founder of Veltmeyer Institute.
Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease https://t.co/UtevQ3NWTE
We look forward to offering FloraStilbene™ to all patients taking immunotherapy, chemotherapy, or radiation therapy that can benefit from immune stimulation of NK cells, T cells, and dendritic cells. https://t.co/rW9wlcMHfW
Although we plan on performing clinical trials to formally establish a level of efficacy, we believe it is imperative to get this drug into the hands of physicians as soon as possible, and we are thankful for having the opportunity to do this today. https://t.co/rW9wlcMHfW
I am honored to partner with Chigurupati and the team at Cure Stat Rx who have second-to-none expertise in compounding and drug formulation across a range of therapeutic indications https://t.co/S4FmuKRNka
STUNNING PAPER...reason for high drug abuse and #suicide in anesthesiologists is because their job causes #inflammation
$TSOI reduces inflammation by #Quadramune
https://t.co/FfF5u9BPx0
Therapeutic Solutions International is focused on product development and concurrently elucidating biological mechanisms of our products, which allow for continuous improvement and credibility in the medical community https://t.co/TFfW3zhCcW
Given that our founding company possesses a wealth of clinical data on mesenchymal stem cells, including FDA Phase III in ARDS, we are currently seeking partners to explore this potentially game-changing discovery https://t.co/mX9RLTgdWO
Frontotemporal dementia is a myriad of different conditions that we have developed a specific diagnostic criterion based on genetic, cellular, and biochemical characteristics of the patients https://t.co/bxRz2ILrl9
I have witnessed first-hand the devastating suffering, both mental and physical, that patients with advanced breast cancer go through https://t.co/YCicCL58rK